Search Results 261-270 of 17660 for ibd

  1. Mayo Clinic researchers to present study findings at American College of Gastroenterologists Annual Scientific Meeting

    Pardi. Anti-tumor necrosis factor (TNF) therapy linked to preeclampsia in women with inflammatory bowel disease. Women with inflammatory bowel disease have ...

  2. Denise B. Klinkner, M.D., M.Ed. - Mayo Clinic Faculty Profiles

    Klinkner also studies chest wall deformities, inflammatory bowel disease (IBD) and fetal surgery topics. In collaboration with Rodrigo Ruano, M.D., Ph.D ...

  3. Analyzing the impact of EHR use on gastroenterology providers - Mayo Clinic

    Subspecialty categories included inflammatory bowel disease (IBD), hepatology (HEP), esophagus (ESO), advanced endoscopy (AE), and motility/irritable bowel ...

  4. Gastroenterology - Mayo Clinic News Network

    IBD Pride Clinic: Belonging while battling bowel disease. Sonya Goins. June 28 ... Mayo Clinic Minute: What is inflammatory bowel disease? Sonya Goins.

  5. Nayantara Coelho-Prabhu, M.B.B.S. - Mayo Clinic Faculty Profiles

    Mayo Clinic researcher Nayantara Coelho-Prabhu, M.B.B.S., studies the epidemiology, diagnosis and management of dysplasia in inflammatory bowel disease.

  6. Inflammatory bowel disease (IBD) · Liver disease; Low vitamin D; Lupus; Medicines and treatments, such as chemotherapy, radiation therapy, pain medicines, heart ...

  7. A Study to Evaluate the Effectiveness and Safety of Vibegron Administered Orally for 12 Weeks to Women with Irritable Bowel Syndrome - Mayo Clinic

    Fecal calprotectin testing is optional and should only be considered if there is a strong suspicion that the subject has IBD (e.g., family history in a 1st ...

  8. Irritable Bowel Syndrome Clinical Trials - Mayo Clinic Research

    ... inflammatory bowel disease (IBD),post-surgical patients with an increased risk of developing paralytic postoperative ileus (POI), and patients with evidence ...

  9. J-pouch disorders: Classification and management - Mayo Clinic

    The prevalence of inflammatory bowel disease is rising, which means there are more patients living with J-pouch than ever before. However, we lack reliable risk ...

  10. Rifaximin (oral route) - Mayo Clinic

    Rifaximin is used to treat traveler's diarrhea that is caused by a bacteria called Escherichia coli. It is also used to prevent hepatic encephalopathy, which is ...